Trial Profile
Therapeutic efficacy of olmesartan, telmisartan and amlodipine to compare with histologic improvement and addciation about AGTR1 gene polymorphisms in subjects with nonalcoholic steatohepatitis (NASH); randomized open-labeled prospective study.
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Olmesartan medoxomil (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 29 Dec 2008 New trial record.